CVE-2025-2744 - "Zhijiantianya Ruoyi-vue-pro Remote Path Traversal Vulnerability"
CVE ID : CVE-2025-2744 Published : March 25, 2025, 7:15 a.m. | 29 minutes ago Description : A vulnerability, which was classified as critical, was found in zhijiantianya ruoyi-vue-pro 2.4.1. Affected is an unknown function of the file /admin-api/mp/material/upload-news-image of the component Material Upload Interface. The manipulation of the argument File leads to path traversal. It is possible to launch the attack remotely. The exploit has been disclosed to the public and may be used. The vendor was contacted early about this disclosure but did not respond in any way. Severity: 5.4 | MEDIUM Visit the link for more details, such as CVSS details, affected products, timeline, and more...
CVE ID : CVE-2025-2744
Published : March 25, 2025, 7:15 a.m. | 29 minutes ago
Description : A vulnerability, which was classified as critical, was found in zhijiantianya ruoyi-vue-pro 2.4.1. Affected is an unknown function of the file /admin-api/mp/material/upload-news-image of the component Material Upload Interface. The manipulation of the argument File leads to path traversal. It is possible to launch the attack remotely. The exploit has been disclosed to the public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.
Severity: 5.4 | MEDIUM
Visit the link for more details, such as CVSS details, affected products, timeline, and more...
Published : March 25, 2025, 7:15 a.m. | 29 minutes ago
Description : A vulnerability, which was classified as critical, was found in zhijiantianya ruoyi-vue-pro 2.4.1. Affected is an unknown function of the file /admin-api/mp/material/upload-news-image of the component Material Upload Interface. The manipulation of the argument File leads to path traversal. It is possible to launch the attack remotely. The exploit has been disclosed to the public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.
Severity: 5.4 | MEDIUM
Visit the link for more details, such as CVSS details, affected products, timeline, and more...
